Concepedia

Author

Kathrin Dieter

Harvard UniversityORCID

Also Known As

K Dieter, Kathrin Dieter

14

Publications

363

Citations

8

H-Index

16

Concepts

All Affiliations

Harvard UniversityRheacell (Germany)Harvard Stem Cell InstituteVA Boston Healthcare SystemEdith Cowan University
KD

About

Kathrin Dieter is an author at Harvard University specializing in cell transplantation, wound healing, and stem cell research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Health Sciences

1

1

77

2

Medicine

1

1

77

3

Cell Biology

1

1

77

4

Immunology

1

1

77

5

Pathology

1

1

77

Kathrin Dieter

×

7

Publications

324

Citations

7

H-Index

YearCitations

Clinical trial of ABCB5+ mesenchymal stem cells for recessive dystrophic epidermolysis bullosa

Dimitra Kiritsi, Kathrin Dieter, Elke Niebergall‐Roth,

JCI Insight

2021

77

Translational development of ABCB5+ dermal mesenchymal stem cells for therapeutic induction of angiogenesis in non-healing diabetic foot ulcers

Andreas Kerstan, Kathrin Dieter, Elke Niebergall‐Roth,

Stem Cell Research & Therapy

2022

62

In vivo safety profile and biodistribution of GMP-manufactured human skin-derived ABCB5-positive mesenchymal stromal cells for use in clinical trials

Nils Tappenbeck, Hannes M. Schröder, Elke Niebergall‐Roth,

Cytotherapy

2019

50

Ex vivo-expanded highly pure ABCB5+ mesenchymal stromal cells as Good Manufacturing Practice-compliant autologous advanced therapy medicinal product for clinical use: process validation and first in-human data

Andreas Kerstan, Elke Niebergall‐Roth, Jasmina Esterlechner,

Cytotherapy

2020

48

Process development and safety evaluation of ABCB5+ limbal stem cells as advanced-therapy medicinal product to treat limbal stem cell deficiency

Alexandra Norrick, Jasmina Esterlechner, Elke Niebergall‐Roth,

Stem Cell Research & Therapy

2021

37

Allogeneic ABCB5+ Mesenchymal Stem Cells for Treatment-Refractory Chronic Venous Ulcers: A Phase I/IIa Clinical Trial

Andreas Kerstan, Kathrin Dieter, Elke Niebergall‐Roth,

JID Innovations

2021

33

ABCB5+ mesenchymal stromal cells facilitate complete and durable wound closure in recessive dystrophic epidermolysis bullosa

Kathrin Dieter, Elke Niebergall‐Roth, Cristina Daniele,

Cytotherapy

2023

17

Page 1